Healthcare and Life Science
Rethinking ADC design: The role of VHHs in precision oncology
Antibody–drug conjugates have become a major platform in precision oncology, combining the targeting ability of antibodies with the potency of cytotoxic payloads. But despite advances in linker chemistry, payload design and antibody engineering, ADC developers still face challenges arou...
Daniel Zeichner MP welcomes Astrazeneca’s £300 million investment as boost for Cambridge
Daniel Zeichner, MP for Cambridge, has welcomed the announcement made by the Prime Minister, Sir Keir Starmer, during Prime Minister’s Questions today that AstraZeneca will invest £300 million into the UK’s life sciences sector. ...
Sable&Hawkes deliver new multi-million environment development project for Luton and Dunstable NHS
Client: Bedfordshire Hospitals NHS Foundation Trust Project: New Acute Services & Multi-Ward Block ...
12 gene therapies converge on retinitis pigmentosa and a $3.4bn market by 2033
This month Gene Scope Intelligence (www.genescope-intelligence.com), a dedicated gene therapy market intelligence platform releases a brand new commercial analysis and demand forecast for new gene therapies directed at Retinitis Pigmentosa (RP). ...
Innovate Cambridge to recognise a new wave of companies at the Business Weekly Awards
Innovate Cambridge has announced a new award category for this year’s prestigious Business Weekly Awards, recognising a new generation of science and technology companies redefining what successful innovation looks like. ...
How movement and physiotherapy can reduce stress at work
Modern workplaces often involve long hours sitting at desks, tight deadlines, and constant digital communication. These factors can significantly increase stress levels and negatively affect both physical and mental health. Incorporating regular movement and physiotherapy principles int...
Lab Thread introduces Unified Lab Software Platform to streamline biological research
Connects scientific teams, data and workflows within a single, fully integrated digital lab management system ...
EpilepsyGTx appoints Professor Dimitri Kullmann as Chief Scientific Officer
Appointment of UCL Neurologist will accelerate the delivery of novel gene therapies for refractory epilepsy ...
Isogenica Ltd. and Axxam S.p.A. Announce Collaboration to Provide Unique VHH Antibody Discovery Solutions
Axxam S.p.A. and Isogenica Ltd. have announced a partnership to bring together functional bioassay capabilities with unique antibody discovery solutions for biotechnology and pharmaceutical clients. ...